Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01976442 · ClinicalTrials.gov registry record
Use of Saline-Washed Platelet and Red Cell Transfusions in Adult Acute Leukemia
A clinical trial of Leukemia, Myeloid, Acute and Leukemia, Lymphoblastic, Acute, sponsored by University of Rochester.
- Completed
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT01976442 is a study of Leukemia, Myeloid, Acute and Leukemia, Lymphoblastic, Acute that has completed, run by University of Rochester. The registered enrollment target is 100 participants, below the 113-participant average among 30 other Leukemia, Myeloid, Acute trials with a reported enrollment target (12% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01976442, a study of Leukemia, Myeloid, Acute and Leukemia, Lymphoblastic, Acute, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether a novel standard of care protocol, washing red cell and platelet transfusions for younger patients with acute leukemia, has yielded improved clinical outcomes at Strong Memorial Hospital (Rochester, New York, USA). This standard of care was implemented based upon an earlier randomized trial (BMC Blood Disorders. 2004 Dec 10;4(1):6) The comparator will be historical controls from the medical literature.
Conditions Studied
Study Locations (1)
New York
- Strong Memorial Hospital (University of Rochester Medical Center) - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2011-03 |
| Est. Completion | 2016-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01976442
The ClinicalTrials.gov registry entry for NCT01976442 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 113-participant average among 30 other Leukemia, Myeloid, Acute trials with a reported enrollment target (12% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Leukemia, Myeloid, Acute appearing as the primary indexed condition, and to 0 interventions.
NCT01976442 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01976442 about?
NCT01976442 is a clinical study titled "Use of Saline-Washed Platelet and Red Cell Transfusions in Adult Acute Leukemia". The purpose of this study is to determine whether a novel standard of care protocol, washing red cell and platelet transfusions for younger patients with acute leukemia, has yielded improved clinical outcomes at Strong Memorial Hospital (Rochester, New York, USA). This standard of care was implement...
What is the current status of trial NCT01976442?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2011-03. Estimated completion is 2016-11.
What conditions does trial NCT01976442 study?
This clinical trial studies the following conditions: Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute.
Who is sponsoring clinical trial NCT01976442?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01976442 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leukemia, Myeloid, Acute
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
RECRUITING · Phase 1
-
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
RECRUITING · Phase 3
-
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
RECRUITING · Phase 1
-
A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy
RECRUITING · Phase 2
-
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
RECRUITING · Phase 2
-
Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AML
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.